SCHEMBL3495656

SCHEMBL3495656

CC(C)(C)OC(=O)n1ccc2c3c(c(S(=O)(=O)O)cc21)NC(C(=O)O)C3

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 1/20 0.33
BUB1 O43683 1/20 0.32
AKT1 P31749 1/20 0.31
ACHE P22303 1/20 0.31
BRD4 O60885 1/20 0.30
CREBBP Q92793 1/20 0.30
ACLY P53396 1/20 0.30
PIK3CD O00329 1/20 0.30
ABL1 P00519 1/20 0.30
EGFR P00533 1/20 0.30
HCK P08631 1/20 0.30
SRC P12931 1/20 0.30
KDR P35968 1/20 0.30
PIK3CA P42336 1/20 0.30
PIK3CB P42338 1/20 0.30
MTOR P42345 1/20 0.30
PIK3CG P48736 1/20 0.30
EPHB4 P54760 1/20 0.30
PRKDC P78527 1/20 0.30
PI4KB Q9UBF8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3497878 0.86
SCHEMBL532457 0.78 BRD4 (0.37) HTR6BUB1AKT1BRD4CREBBP
SCHEMBL26683889 0.62 BUB1 (0.38) HTR6BUB1AKT1PIK3CDABL1
SCHEMBL3237691 0.61 L3MBTL1 (0.44) HTR6BUB1AKT1ACHEBRD4
SCHEMBL29507077 0.61 L3MBTL1 (0.44) HTR6BUB1AKT1ACHEBRD4
SCHEMBL24549029 0.61 USP30 (0.40) HTR6BUB1AKT1ACLYPIK3CD
SCHEMBL3339983 0.61 PIK3CA (0.38) HTR6BUB1AKT1BRD4ACLY
SCHEMBL24539514 0.61 HSP90AA1 (0.39) HTR6BUB1AKT1PIK3CDABL1
SCHEMBL20789959 0.61 L3MBTL1 (0.42) HTR6BUB1AKT1BRD4CREBBP
SCHEMBL23042963 0.61 BUB1 (0.37) HTR6BUB1AKT1BRD4CREBBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7851606-B2 Negatively charged minor groove binders ELITECH HOLDING B.V. (NL) 2010-12-14 US disclosed
US-20100137614-A1 NEGATIVELY CHARGED MINOR GROOVE BINDERS EPOCH BIOSCIENCES, INC. (US) 2010-06-03 US disclosed
US-7582739-B2 Negatively charged minor groove binders EPOCH BIOSCIENCES, INC. (US) 2009-09-01 US disclosed
US-20050187383-A1 Negatively charged minor groove binders LUKHTANOV, EUGENE 2005-08-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050187383-A1 Negatively charged minor groove binders PCNA, NCL, HNRNPH3 HTR6 3933/4885BUB1 3973/4885AKT1 4865/4885
US-20100137614-A1 NEGATIVELY CHARGED MINOR GROOVE BINDERS PCNA, NCL, HNRNPH3 HTR6 3933/4885BUB1 3973/4885AKT1 4865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.